Atrial fibrillation


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Tests and diagnosis

By Mayo Clinic staff

Heart-Healthy Living

Subscribe to our Heart-Healthy Living e-newsletter to stay up to date on heart-health topics.

Sign up now

To diagnose atrial fibrillation, your doctor may do tests that involve the following:

  • Electrocardiogram (ECG). In this noninvasive test, patches with wires (electrodes) are attached to your skin to measure electrical impulses given off by your heart. Impulses are recorded as waves displayed on a monitor or printed.
  • Holter monitor. This is a portable machine that records all of your heartbeats. You wear the monitor under your clothing. It records information about the electrical activity of your heart as you go about your normal activities for a day or two. You can press a button if you feel symptoms, so your doctor can know what heart rhythm was present at that moment.
  • Event recorder. This device is similar to a Holter monitor except that not all of your heartbeats are recorded. There are two recorder types: One uses a phone to transmit signals from the recorder while you're experiencing symptoms. The other type is worn all the time (except while showering) for as long as a month. Event recorders are especially useful in diagnosing rhythm disturbances that occur at unpredictable times.
  • Echocardiogram. In this noninvasive test, sound waves are used to produce a video image of your heart. Sound waves are directed at your heart from a wand-like device (transducer) that's held on your chest. The sound waves that bounce off your heart are reflected through your chest wall and processed electronically to provide video images of your heart in motion, to detect underlying structural heart disease.
  • Blood tests. These help your doctor rule out thyroid problems or other substances in your blood that may lead to atrial fibrillation.
  • Chest X-ray. X-ray images help your doctor see the condition of your lungs and heart. Your doctor can also use an X-ray to diagnose conditions other than atrial fibrillation that may explain your signs and symptoms.
References
  1. Atrial fibrillation (Afib). Heart Rhythm Society. http://www.hrsonline.org/Patient-Resources/Heart-Diseases-Disorders/Atrial-Fibrillation-AFib. Accessed Dec. 19, 2012.
  2. Atrial fibrillation. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/af/. Accessed Dec. 19, 2012.
  3. Verdecchia P, et al. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE intolerant subjects with cardiovascular disease studies. Journal of Hypertension. 2012;30:1004.
  4. Furie KL, et al. Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: A science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:3442.
  5. Pradaxa (prescribing information). Ridgefield, Conn.: Boehringer Ingelheim Pharmaceuticals; 2012. https://www.pradaxa.com/pradaxa-prescribing-information.jsp. Accessed Dec. 19, 2012.
  6. Cardioversion. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/crv/. Accessed Dec. 19, 2012.
  7. Catheter ablation. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/ablation/. Accessed Dec. 19, 2012.
  8. Cheng J, et al. Surgical approaches to prevent recurrent atrial fibrillation. http://www.uptodate.com/home. Accessed Dec. 19, 2012.
  9. Kumar K. Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations. http://www.uptodate.com/home. Accessed Dec. 19, 2012.
  10. Wann LS, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;57:223.
  11. Xarelto (prescribing information). Titusville, N.J.: Jansen Pharmaceuticals; 2012. http://www.xareltorems.com/rems/xarelto-prescribing-information.html. Accessed Dec. 19, 2012.
  12. How the heart works. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/chd/heartworks.html. Accessed Dec. 19, 2012.
  13. FDA drug safety communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves. U.S. Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/ucm332912.htm. Accessed Dec. 27, 2012.
DS00291 Feb. 8, 2013

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger